Related Experiment Videos
[Epidemiology of resistance to antibiotics in respiratory tract infections]
1Laboratoire de Bactériologie, Groupe Hospitalier Bichat-Claude Bernard, Paris. claudette.muller@bch.ap-hop-paris.fr
Abstract:
AN EVOLVING PROBLEM: Antibiotic resistance currently concerns H. influenzae, S. pneumoniae, S. pyogenes, M. catarrhalis, all species which are particularly susceptible to beta-lactamines, fluoroquinolones and macrolides. Incidence of resistance has reached high levels in many countries, including France in certain instances. BETA-LACTAMINE RESISTANCE: Penicillin-resistant pneumococci (partial and total resistance) are unequally distributed over the globe. In France the frequency is high, particularly in children. S. pyogenes strains remain sensitive to peni-G. Amino-penicillin resistance of H. influenzae and M. catarrhalis results from enzymatic processes (penicillinase production) and concerns an important proportion of the strains, particularly for M. catarrhalis. FLUOROQUINOLONE-RESISTANCE: Fluoroquinolone resistance is now described for H. influenzae. Though rare, this is a serious problem as it proves that this bacterial species can adapt to new antibiotics used for the treatment of respiratory tract infections. Resistance is acquired by modifying the antibiotic target, DNA gyrase and/or topo-isomerases, enzyme implicated in bacterial DNA. The presence of multiple mutations in the genes coding for these enzymes raises the MIC for fluoroquinolones, including those for the most recent compounds. Streptococci resistance to fluoroquinolones is increasing but no new mechanisms of resistance have been described. MACROLIDE-RESISTANT STREPTOCOCCI: Acquired resistance results either from the presence of erm genes causing a modification in the bacterial ribosome by methylation or by the presence of mef genes coding for efflux proteins. Incidence of macrolide resistance and the distribution of these different mechanisms vary greatly from one country to another. EMPIRICAL TREATMENT OF RESPIRATORY TRACT INFECTIONS: Epidemiological data and the locoregional bacterial ecology must be considered when prescribing an empirical treatment for respiratory tract infections.
Insights
Antibiotic resistance in common respiratory pathogens like Streptococcus pneumoniae is a growing global concern. Understanding resistance patterns is crucial for effective empirical treatment of infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Antibiotic resistance is a significant challenge for common respiratory pathogens, including Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, and Moraxella catarrhalis.
- These bacteria are frequently treated with beta-lactamines, fluoroquinolones, and macrolides, and resistance to these drug classes is increasing globally.
- High incidences of resistance have been reported in various countries, necessitating a re-evaluation of treatment strategies.
Purpose of the Study:
- To review the current landscape of antibiotic resistance in key respiratory tract pathogens.
- To highlight the mechanisms and prevalence of resistance to beta-lactamines, fluoroquinolones, and macrolides.
- To emphasize the importance of epidemiological data and local bacterial ecology in guiding empirical treatment decisions for respiratory infections.
Main Methods:
- Review of existing literature on antibiotic resistance patterns.
- Analysis of resistance mechanisms, including enzymatic processes (penicillinase production) and target modification (DNA gyrase, topoisomerases).
- Examination of genetic determinants of resistance, such as erm and mef genes.
Main Results:
- Penicillin resistance in Streptococcus pneumoniae is geographically widespread and particularly high in France.
- Haemophilus influenzae and Moraxella catarrhalis exhibit significant amino-penicillin resistance due to penicillinase production.
- Fluoroquinolone resistance in Haemophilus influenzae, though rare, is concerning, indicating bacterial adaptation. Streptococci also show increasing fluoroquinolone resistance.
- Macrolide resistance in streptococci is mediated by erm or mef genes, with varying prevalence and mechanisms globally.
Conclusions:
- Antibiotic resistance in respiratory pathogens is an evolving problem requiring continuous monitoring.
- Resistance patterns vary significantly by geographic location and bacterial species.
- Empirical antibiotic treatment for respiratory tract infections must consider local epidemiological data and bacterial ecology.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Microbiota of the Respiratory Tract
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Antibiotic Selection
Microbiota Modulation by Antibiotics